[1]Patent:WO2016/201096,2016,A1.Locationinpatent:Paragraph00197
[1]CurrentPatentAssignee:CANCERTHERAPEUTICSCRCPTYLTD-WO2019/243491,2019,A1Locationinpatent:Page/Pagecolumn184-185
[1]Patent:WO2019/243491,2019,A1.Locationinpatent:Page/Pagecolumn184
89692-53-5
36216-80-5
868271-15-2
1344702-32-4
927413-64-7
16263-60-8
80166-01-4 | 4-(Morpholin-4-ylmethyl)phenol | AA005NZO | MFCD01467510
71935-32-5 | 4-(Hydroxymethyl)picolinonitrile | AA005OR8 | MFCD07367897
77169-11-0 | 3-Methyl-1-phenyl-1h-pyrazole-4-carboxylic acid | AA005P9K | MFCD01415214
672-18-4 | 2-Butenedioic acid,2-fluoro-, (2Z)- | AA005Q11 | MFCD31443801
676501-87-4 | 5-(Methoxycarbonyl)furan-2-boronic acid pinacol ester | AA005QXU | MFCD11846466
77817-12-0 | Methyl 6-aminopyrimidine-4-carboxylate | AA005RNL | MFCD13174840
95262-02-5 | 3-((2,3-Dimethylphenyl)amino)-3-oxopropanoic acid | AA005SDS | MFCD08685825
7151-77-1 | Ethyl 4-(methylsulfonamido)benzoate | AA005SZF | MFCD00025051
7749-48-6 | 4-Ethoxy-6-methylpyrimidin-2-amine | AA005TP1 | MFCD02685668
714278-20-3 | 1-Isobutyl-2-methyl-1H-indole-3-carbaldehyde | AA005UEP | MFCD05998744